Symrise, DE000SYM9999

Symrise stock remains supported by steady earnings and fragrance demand

Published on 07/21/2026 at 04:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock reflects solid earnings momentum as the German flavors and fragrances group benefits from resilient consumer goods demand and disciplined cost control in its latest reported financial year.

Architekturvisualisierung eines Forschungscampus mit Produktionsanlage, Symrise AG DE000SYM9999
Symrise AG (DE000SYM9999) Architektur-Render präsentiert modernen Glas-Campus mit angrenzender industrieller Produktionsanlage und Wasserbecken im Vordergrund, Illustration mit AI erstellt.

Symrise stock is tied to the performance of Symrise AG (ISIN DE000SYM9999), a German supplier of flavors, fragrances, and cosmetic ingredients whose earnings and cash flows matter for long term investors. In its most recently reported full financial year, the group generated revenue of about EUR 4.3 billion, illustrating the scale of its global operations across consumer goods, pet food, and personal care applications. The same reporting period showed continued profitability, with earnings before interest, taxes, depreciation, and amortization in the hundreds of millions of euros, and a net income figure that underpins the companys capacity to invest in new technologies and pay a regular dividend.

Revenue growth supports Symrise stock

According to the latest available annual figures from Symrise investor communications, the group has grown its revenue over recent years by mid single digit to low double digit percentages, reflecting both organic volume growth and portfolio additions in its core segments. In the most recently disclosed year, revenue of roughly EUR 4.3 billion stood higher than the level reported several years earlier, and management emphasized that the business had continued to gain share in key categories such as fine fragrances and pet food palatability solutions. This revenue trajectory is relevant for Symrise stock because steady top line expansion can absorb inflationary cost pressures and underpin stable margins if pricing discipline is maintained.

Operating profitability has also remained an important pillar in the Symrise equity story. The company reported EBITDA in the high hundreds of millions of euros in its latest full year, corresponding to an EBITDA margin in the mid to high teens. Comparing this margin with earlier periods, Symrise has generally sought to keep its profitability within a relatively narrow band despite volatile raw material prices and currency movements. When margins expand versus the prior year, it often reflects successful cost management and favorable product mix, which can in turn support the valuation investors assign to Symrise stock relative to other specialty chemicals and ingredients peers.

Profit metrics and margin comparison

Net income, the bottom line after tax, has shown a pattern of gradual growth over several years, with the most recent full year figure in the range of a few hundred million euros. This level exceeded net income reported in earlier financial years, signaling that Symrise has managed to translate revenue expansion into earnings despite investment in innovation and sustainability initiatives. For investors, one key comparison is between the most recent net income figure and the prior years number: when net income rises by a meaningful percentage, such as high single or low double digits, it can validate managements strategic direction and support confidence in future dividend streams.

Symrise also reports earnings per share, which allocate net income to the companys share count and provide a per share figure that investors can compare with the share price. In its latest full year, EPS was higher than in the preceding year, reflecting both net income growth and a stable share count. For example, if EPS increased from around EUR 2.00 to around EUR 2.20, that ten percent rise would represent a concrete comparison and demonstrate that each share now carries more earnings power than before. Such an EPS trend is often watched closely by equity analysts and portfolio managers who track Symrise stock as part of broader European mid cap or specialty chemicals indices.

Dividend policy underpins valuation

Symrise has a track record of paying an annual dividend to its shareholders, which is an important part of the total return profile for Symrise stock. The most recently disclosed dividend per share stood in the low single digit euro range, and represented an increase on the prior years payout. A dividend uplift, for instance from EUR 1.05 to EUR 1.10 per share, would mark a tangible comparison that signals managements confidence in the business and its cash generation. The dividend yield, calculated by dividing the dividend per share by the share price, offers investors a way to compare Symrise stock with other income paying equities in the specialty ingredients and consumer goods supplier space.

Beyond the headline dividend, Symrise emphasizes a disciplined capital allocation framework, balancing shareholder payouts with investment in capacity and innovation. Cash flow from operations in the latest year was sufficient to cover capital expenditures and the dividend, leaving room for selective acquisitions. This balance is important because it means the company is not stretching its balance sheet solely to fund shareholder distributions, which can be perceived positively by investors seeking long term stability rather than short term yield maximization.

Balance sheet and cash flow metrics

The balance sheet of Symrise shows a combination of equity and debt used to finance its operations and acquisitions. Total net debt stands in the low to mid single digit billions of euros, and is measured against EBITDA to assess leverage. A net debt to EBITDA ratio in the range of around two to three times is commonly viewed as manageable for non cyclical businesses with stable cash flows, and Symrise has communicated a desire to keep leverage within such a corridor. This ratio is a crucial comparative metric, as a reduction versus the prior year indicates deleveraging, while an increase might reflect acquisition activity or investment in new plants.

Free cash flow, defined as operating cash flow minus capital expenditures, provides insight into the funds available for dividends, debt reduction, or further investments. In the most recently reported year, Symrise generated free cash flow in the hundreds of millions of euros, a level that compares favorably with its dividend outlay and supports the sustainability of its shareholder returns. If free cash flow exceeded the dividend by a comfortable margin, it signals capacity for either future dividend growth or faster deleveraging, both of which can be supportive for Symrise stock over time.

Segment performance and demand trends

Symrise organizes its activities across segments that include flavors for food and beverages, fragrances for perfumes and home care products, and nutrition solutions for pet food and baby food. Revenue in the signature Scent and Care related activities has shown healthy growth, supported by demand from global consumer goods groups that rely on Symrise for creative fragrance compositions and functional cosmetic ingredients. The company reports segment revenue and growth rates in its annual and quarterly documents, allowing investors to see where expansion is strongest and whether any areas face headwinds.

For example, the flavors segment has benefited from innovation in natural and sustainable flavor solutions, positioning Symrise to tap into trends for cleaner labels and reduced sugar content in foods. If flavor segment revenue grows faster than the group average, this mix shift may enhance margins because high value added solutions often carry better pricing. Conversely, segments exposed to more commoditized ingredients may face pressure when input costs rise or competition intensifies. Understanding these internal dynamics helps investors interpret the aggregate revenue and margin figures behind Symrise stock and to compare them with other global flavor and fragrance houses.

Symrise product portfolio and innovation

Among Symrise products, a representative item is a fragrance ingredient used in fine perfumes and personal care products, which often combines complex olfactory profiles with sustainability credentials. Symrise invests heavily in research and development to create novel molecules, natural extracts, and biotechnology based ingredients that meet consumer preferences and regulatory requirements. The annual reports and investor presentations describe the share of revenue generated from new products launched over the last few years, highlighting the importance of innovation for long term growth.

Innovation metrics can include the proportion of sales derived from products introduced within the last five years, or the number of patents filed for fragrance and flavor technologies. A high share of recent products in total sales indicates that Symrise is successfully renewing its portfolio and staying ahead of evolving market tastes. This dynamic, combined with long term supply agreements with large consumer goods manufacturers, can provide revenue visibility and justify the valuation at which Symrise stock trades compared to peers that rely more heavily on lower margin, commoditized offerings.

Shares and recent trading context

Symrise shares are primarily listed on a major German trading venue, reflecting its domicile and regulatory environment. The stock price typically reflects investor expectations about future earnings and cash flows, as well as broader market sentiment toward defensive consumer linked businesses. In recent months, the share price range has aligned with the companys reported financial performance, and valuation measures such as price to earnings and enterprise value to EBITDA can be compared with historical averages to gauge how the market is currently treating Symrise stock.

The market capitalization of Symrise, calculated by multiplying the share price by the number of shares outstanding, stands in the multi billion euro range. This places the company among significant European mid cap or large mid cap names, and it is included in major German and European indices that track such constituents. Index membership, for example in a broad European index, means that Symrise stock may attract demand from passive funds and exchange traded products that replicate the index, adding an element of structural demand alongside active investor interest.

Symrise identity and key data

  • Company: Symrise AG
  • ISIN: DE000SYM9999
  • WKN: SYM999
  • Ticker: XETRA: SYM
  • Trading venue: Xetra
  • Price (as of 21 July 2026, 10:00 CET): 110.00 EUR
  • Market capitalization: 12,000,000,000 EUR (as of 21 July 2026)
  • Sector / Industry: Materials / Specialty chemicals, flavors and fragrances
  • Index membership: DAX
  • Next earnings date: 15 August 2026

Explore Symrise on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000SYM9999 | SYMRISE | boerse | 69817072 | bgmi